| Názov | Neoplasma : journal of experimental and clinical oncology / Cancer Research Institute of the Slovak Academy of Sciences
|
|---|
| Roč., číslo | Vol. 67, no. 4, rok 2020
|
|---|
| ISSN | 0028-2685
|
|---|
| Vyd.údaje | Bratislava : AEPress, 2020
|
|---|
| Fyz.popis | s. 715-945
|
|---|
| Súborný záznam | Neoplasma
|
|---|
|
|
|---|
| Jazyk dok. | Angličtina
|
|---|
| Krajina | Slovensko
|
|---|
| Počet ex. | 2, z toho voľných 0, prezenčne 2
|
|---|
| Báza dát | PERIODIKÁ - Prijaté čísla
|
|---|
| Obsah | Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS):.. / V. Sandecka ... [et al.]
|
|---|
| The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL / / M. Kicova ... [et al.]
|
|---|
| Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer:.. / W. S. Chen ... [et al.]
|
|---|
| Study of DOK4 gene expression and promoter methylation in sporadic breast cancer / / A. Heidarizadi ... [et al.]
|
|---|
| Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma / / M. M. Chen ... [et al.]
|
|---|
| Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors / / S. Shinriki
|
|---|
| Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR.. / H. Wei ... [et al.]
|
|---|
| O-GlcNA cylation promotes malignant phenotypes of bladder cancer cells / / L. Jin ... [et al.]
|
|---|
| LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis / / Z. Qiu ... [et al.]
|
|---|
| Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing.. / J. H. Yuan ... [et al.]
|
|---|
| The tumor suppressor NOR1 suppresses cell growth, invasiveness, and tumorigenicity in glioma / / J. Cai ... [et al.]
|
|---|
| Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27 / / J. Li ... [et al.]
|
|---|
| Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway / / X. X. Jiao ... [et al.]
|
|---|
| miR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer / / S. Wang ... [et al.]
|
|---|
| miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2 / / Z. R. Zhang, N. Yang
|
|---|
| The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung.. / C. M. Wei ... [et al.]
|
|---|
| SOCS2 affects the proliferation, migration, and invasion of nasopharyngeal carcinoma cells via regulating EqhA1 / / B. Dai, X. Zhang
|
|---|
| LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis / / C. Xu ... [et al.]
|
|---|
| miR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells / / J. Ye ... [et al.]
|
|---|
| Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT.. / L. Zhang ... [et al.]
|
|---|
| LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to.. / G. Jin ... [et al.]
|
|---|
| SKA2 promotes proliferation and invasion of hepatocellular carcinoma cells via activating the β-catenin signaling pathway / / D. Wang ... [et al.]
|
|---|
| Regulation of HBV replication and gene expression by miR-501-3p via targeting ZEB2 in hepatocellular carcinoma / / Z. J. Zhong ... [et al.]
|
|---|
| miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells / / S. Gao ... [et al.]
|
|---|
| Adverse events and management of apatinib in patients with advanced or metastatic cancers: A review / / F. Shao ... [et al.]
|
|---|
